Covidien and 2 Popular Stocks Making Moves After Earnings

ResMed Inc. (NYSE:RMD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Net income increased 23.91% to $77.9 million (53 cents per diluted share) in the quarter versus a net gain of $62.87 million in the year-earlier quarter. Revenue Rose 13.15% to $376.5 million from the year-earlier quarter.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

ResMed Inc. reported adjusted net income of 53 cents per share. By that measure, the company beat the mean analyst estimate of $0.51. It beat the average revenue estimate of $363.76 million.

RMD

Covidien plc (NYSE:COV) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Net income decreased -0.2% to $493 million ($1.1 per diluted share) in the quarter versus a net gain of $494 million in the year-earlier quarter. Revenue rose 5.59% to $3.06 billion from the year-earlier quarter.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Covidien plc reported adjusted net income of $1.1 per share. By that measure, the company beat the mean analyst estimate of $1.06. It beat the average revenue estimate of $3 billion.

COV

Immunogen Inc. (NASDAQ:IMGN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Net loss increased 91.37% to $24.4 million (29 cents per diluted share) in the quarter versus a net loss of $12.75 million in the year-earlier quarter. Revenue decreased 65.88% to $2.6 million from the year-earlier quarter.

Immunogen Inc. reported adjusted net income of 28 cents per share. By that measure, the company missed the mean analyst estimate of $-0.25. It missed the average revenue estimate of $6.02 million.

IMGN

Don’t Miss: Is Britain Headed For a Third Recession?